JLHL (Julong Holding Limited Class A Ordinary Shares) Stock Analysis - News

Julong Holding Limited Class A Ordinary Shares (JLHL) is a publicly traded Industrials sector company. As of May 19, 2026, JLHL trades at $24.21 with a market cap of $498.90M and a P/E ratio of 0.00. JLHL moved -3.27% today. Year to date, JLHL is +495.86%; over the trailing twelve months it is flat. Its 52-week range spans $2.70 to $32.85. Rallies surfaces JLHL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in JLHL news today?

Jupiter Life Line Reports 15.2% FY26 Income Growth, Opens Dombivli Hospital: Jupiter Life Line Hospitals posted FY26 income of INR 1,499.8 cr (up 15.2%) with EBITDA of INR 343.3 cr (22.9% margin) and PAT of INR 194.2 cr, while Q4 revenue rose 15.1% to INR 387.8 cr. The company holds INR 545 cr cash vs INR 500 cr debt and opened its Dombivli hospital.

JLHL Key Metrics

Key financial metrics for JLHL
MetricValue
Price$24.21
Market Cap$498.90M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$32.85
52-Week Low$2.70
Volume243
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest JLHL News

JLHL Analyst Consensus

JLHL analyst coverage data. Average price target: $0.00.

Common questions about JLHL

What changed in JLHL news today?
Jupiter Life Line Reports 15.2% FY26 Income Growth, Opens Dombivli Hospital: Jupiter Life Line Hospitals posted FY26 income of INR 1,499.8 cr (up 15.2%) with EBITDA of INR 343.3 cr (22.9% margin) and PAT of INR 194.2 cr, while Q4 revenue rose 15.1% to INR 387.8 cr. The company holds INR 545 cr cash vs INR 500 cr debt and opened its Dombivli hospital.
Does Rallies summarize JLHL news?
Yes. Rallies summarizes JLHL news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is JLHL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JLHL. It does not provide personalized investment advice.
JLHL

JLHL